Cargando…
The potential of serum neurofilament as biomarker for multiple sclerosis
Multiple sclerosis is a highly heterogeneous disease, and the detection of neuroaxonal damage as well as its quantification is a critical step for patients. Blood-based serum neurofilament light chain (sNfL) is currently under close investigation as an easily accessible biomarker of prognosis and tr...
Autores principales: | Bittner, Stefan, Oh, Jiwon, Havrdová, Eva Kubala, Tintoré, Mar, Zipp, Frauke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634125/ https://www.ncbi.nlm.nih.gov/pubmed/34180982 http://dx.doi.org/10.1093/brain/awab241 |
Ejemplares similares
-
Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021) -
Supplementary medication in multiple sclerosis: Real-world experience
and potential interference with neurofilament light chain
measurement
por: Pape, Katrin, et al.
Publicado: (2020) -
Implications of extreme serum neurofilament light chain levels for
the management of patients with relapsing multiple sclerosis
por: Engel, Sinah, et al.
Publicado: (2021) -
Serum neurofilament levels reflect outer retinal layer changes in
multiple sclerosis
por: Seitz, Caspar B., et al.
Publicado: (2021) -
Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort
por: Steffen, Falk, et al.
Publicado: (2022)